|
RESEARCH
The Importance of Research at Henderson Behavioral Health
Research paves the way for prevention, recovery and cure and HBH is committed to contributing to that knowledge base. HBH participates in cutting-edge research on evidence based practices, emerging best practices and recovery-promoting services for individuals with severe mental illness. Systematic pursuit and dissemination of such knowledge, has been a cornerstone of HBH’s long history. |
- HBH participated in its first NIMH-funded project entitled “Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study.” This was a 5 year nationwide, public health-focused clinical trial that compared the effectiveness of older (first available in the 1950s) and newer (available since the 1990s) antipsychotic medications used to treat schizophrenia. HBH was one of 57 clinical sites around the nation that helped explore this question. The study had vital public health implications because it provided doctors and patients with much-needed information comparing medication treatment options. It was the largest, longest, and most comprehensive independent trial ever done to examine existing therapies for this disease.
- From 2006 to 2010, HBH was selected as one of only 20 sites for the “Mental Health Treatment Study,” sponsored by the Social Security Administration. Henderson was selected for the study on the basis of its historical performance with evidence-based supported employment. The 4-year study concluded in July 2010, and examined the value of eliminating disincentives from the workplace, establishing an accurate diagnosis and delivering appropriate mental health and employment supports for study participants. Outcomes assessed included employment, health and mental status, quality of life, functioning, and clinical recovery. Study participants were selected from Social Security Disability Insurance beneficiaries and had a primary impairment of schizophrenia or affective disorder. Westat, an employee-owned research corporation based in Rockville, MD, conducted the study, along with Dartmouth University, the University of Texas, the University of Maryland at Baltimore County and Indiana University-Purdue University Indianapolis.
|
|
|
Currently, HBH is involved in one critical study:
- In January 2010, Henderson Behavioral Health was selected as one of thirty leading behavioral healthcare organizations from across the nation, to participate in a new National Institute of Mental Health (NIMH) research study. The study is designed to evaluate the benefits of a comprehensive pharmacological and psychosocial treatment package (referred to as the RAISE Enhanced Treatment Program) for individuals with first episode psychosis, compared to a typical community mental health treatment (community care). The goals of the study are to improve the long-term trajectory of schizophrenia and reduce its disability over the lifetime by providing rapid, comprehensive, effective treatment at the first episode of psychosis. Also, the study seeks to develop and evaluate an intervention for first episode psychosis that can be delivered in a wide range of clinical settings and can be paid for by existing funding mechanisms. The program is led by Dr. John Kane at the Zucker Hillside Hospital in New York with colleagues from Dartmouth Medical School, University of North Carolina at Chapel Hill, Yale Medical School, University of Calgary, UCLA, and SUNY Downstate Medical Center.
|
